Cargando…
Hepatitis E Virus: How It Escapes Host Innate Immunity
Hepatitis E virus (HEV) is a leading cause of viral hepatitis in the world. It is usually responsible for acute hepatitis, but can lead to a chronic infection in immunocompromised patients. The host’s innate immune response is the first line of defense against a virus infection; there is growing evi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564545/ https://www.ncbi.nlm.nih.gov/pubmed/32731452 http://dx.doi.org/10.3390/vaccines8030422 |
_version_ | 1783595739022098432 |
---|---|
author | Lhomme, Sébastien Migueres, Marion Abravanel, Florence Marion, Olivier Kamar, Nassim Izopet, Jacques |
author_facet | Lhomme, Sébastien Migueres, Marion Abravanel, Florence Marion, Olivier Kamar, Nassim Izopet, Jacques |
author_sort | Lhomme, Sébastien |
collection | PubMed |
description | Hepatitis E virus (HEV) is a leading cause of viral hepatitis in the world. It is usually responsible for acute hepatitis, but can lead to a chronic infection in immunocompromised patients. The host’s innate immune response is the first line of defense against a virus infection; there is growing evidence that HEV RNA is recognized by toll-like receptors (TLRs) and retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs), leading to interferon (IFN) production. The IFNs activate interferon-stimulated genes (ISGs) to limit HEV replication and spread. HEV has developed strategies to counteract this antiviral response, by limiting IFN induction and signaling. This review summarizes the advances in our knowledge of intracellular pathogen recognition, interferon and inflammatory response, and the role of virus protein in immune evasion. |
format | Online Article Text |
id | pubmed-7564545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75645452020-10-29 Hepatitis E Virus: How It Escapes Host Innate Immunity Lhomme, Sébastien Migueres, Marion Abravanel, Florence Marion, Olivier Kamar, Nassim Izopet, Jacques Vaccines (Basel) Review Hepatitis E virus (HEV) is a leading cause of viral hepatitis in the world. It is usually responsible for acute hepatitis, but can lead to a chronic infection in immunocompromised patients. The host’s innate immune response is the first line of defense against a virus infection; there is growing evidence that HEV RNA is recognized by toll-like receptors (TLRs) and retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs), leading to interferon (IFN) production. The IFNs activate interferon-stimulated genes (ISGs) to limit HEV replication and spread. HEV has developed strategies to counteract this antiviral response, by limiting IFN induction and signaling. This review summarizes the advances in our knowledge of intracellular pathogen recognition, interferon and inflammatory response, and the role of virus protein in immune evasion. MDPI 2020-07-28 /pmc/articles/PMC7564545/ /pubmed/32731452 http://dx.doi.org/10.3390/vaccines8030422 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Lhomme, Sébastien Migueres, Marion Abravanel, Florence Marion, Olivier Kamar, Nassim Izopet, Jacques Hepatitis E Virus: How It Escapes Host Innate Immunity |
title | Hepatitis E Virus: How It Escapes Host Innate Immunity |
title_full | Hepatitis E Virus: How It Escapes Host Innate Immunity |
title_fullStr | Hepatitis E Virus: How It Escapes Host Innate Immunity |
title_full_unstemmed | Hepatitis E Virus: How It Escapes Host Innate Immunity |
title_short | Hepatitis E Virus: How It Escapes Host Innate Immunity |
title_sort | hepatitis e virus: how it escapes host innate immunity |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564545/ https://www.ncbi.nlm.nih.gov/pubmed/32731452 http://dx.doi.org/10.3390/vaccines8030422 |
work_keys_str_mv | AT lhommesebastien hepatitisevirushowitescapeshostinnateimmunity AT migueresmarion hepatitisevirushowitescapeshostinnateimmunity AT abravanelflorence hepatitisevirushowitescapeshostinnateimmunity AT marionolivier hepatitisevirushowitescapeshostinnateimmunity AT kamarnassim hepatitisevirushowitescapeshostinnateimmunity AT izopetjacques hepatitisevirushowitescapeshostinnateimmunity |